Churg-Strauss syndrome: Survival for 26 years

Preeti Vemuri, Paul A. Greenberger*, Roy Patterson

*Corresponding author for this work

Research output: Contribution to journalArticle

9 Scopus citations


USABackground: Churg-Strauss syndrome (CSS), a necrotizing vasculitis characterized by asthma and eosinophilia, was described initially in 1951. Before the use of oral corticosteroids, the average patient survived for only a few months. Today with the use of oral corticosteroids and immunosuppressants, survival has increased significantly. Methods: We report the case of a patient with CSS treated with prednisone and azathioprine. A review of the English literature was performed with MEDLINE from 1966 to the present using these keywords: Churg-Strauss syndrome, survival, prognosis, morbidity, mortality, and treatment. Results: This patient survived 26 years after the diagnosis of CSS and died without autopsy findings of active vasculitis. This is the longest reported survival with CSS in the English literature to our knowledge. The patient's disease course was marked by two acute (vasculitic) episodes, with intermittent subacute disease, and finally a state of disease remission. Conclusions: Survival in patients with CSS can be prolonged with early initiation of corticosteroids and immunosuppressants, close outpatient followup, and prompt, aggressive treatment of relapses. This case exemplifies the disease progression and remission as reported by other authors. We propose that CSS can be classified into acute (vasculitic), subacute, and remittable stages.

Original languageEnglish (US)
Pages (from-to)640-643
Number of pages4
JournalAnnals of Allergy, Asthma and Immunology
Issue number6
StatePublished - Jun 1 2002

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Churg-Strauss syndrome: Survival for 26 years'. Together they form a unique fingerprint.

  • Cite this